Leap Therapeutics, Inc. (LPTX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 81.92M | 162.08M | 178.5M | 19.16M | 33.87M | 48.04M | 63.81M | 294.24M | 188.2M | 71.6M | 81.76M | 93.88M |
| Cash & Short-Term Investments | 6.69M | 14.04M | 174.14M | 18.13M | 32.71M | 47.25M | 62.82M | 292.87M | 180.65M | 70.64M | 80.74M | 91.42M |
| Cash Only | 6.69M | 14.04M | 26.76M | 18.13M | 32.71M | 47.25M | 62.82M | 252M | 142.12M | 70.64M | 80.74M | 91.42M |
| Short-Term Investments | 0 | 0 | 147.38M | 0 | 0 | 0 | 0 | 40.87M | 38.53M | 0 | 0 | 0 |
| Accounts Receivable | 74.47M | 148.01M | 179K | 739K | 711K | 704K | 780K | 142K | 999K | 771K | 753K | 2.05M |
| Days Sales Outstanding | - | - | 202.05 | - | - | 291.73 | - | - | - | 208.02 | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 768K | 40K | 0 | 292K | 446K | 86K | 209K | 0 | 5.27M | 183K | 265K | 419K |
| Total Non-Current Assets | 5.46M | 1.1M | 116.33M | 881K | 1.01M | 1.08M | 1.24M | 91.68M | 90.09M | 1.23M | 1.28M | 1.98M |
| Property, Plant & Equipment | 38K | 38K | 65.89M | 38K | 152K | 262K | 370K | 16.77M | 15.36M | 262K | 372K | 480K |
| Fixed Asset Turnover | - | - | 0.01x | - | - | 0.74x | - | - | - | 1.06x | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24.06M | 24.06M | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 50M | 0 | 0 | 0 | 0 | 50M | 50M | 0 | 0 | 0 |
| Long-Term Investments | 5M | 150K | 0 | 59K | 55K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 418K | 913K | 438K | 784K | 802K | 823K | 865K | 854K | 664K | 966K | 913K | 1.5M |
| Total Assets | 87.38M | 163.18M | 294.82M | 20.04M | 34.88M | 49.12M | 65.05M | 385.92M | 278.29M | 72.83M | 83.05M | 95.86M |
| Asset Turnover | - | - | 0.00x | - | - | 0.00x | - | - | - | 0.00x | - | - |
| Asset Growth % | 150.52% | 232.18% | 353.25% | -94.81% | -87.47% | -32.55% | -21.67% | 302.6% | 161.19% | 25.36% | 25.61% | 42.53% |
| Total Current Liabilities | 3M | 4.56M | 20.62M | 14.32M | 14.04M | 14.08M | 16.09M | 10.61M | 14.5M | 12.68M | 11.04M | 11.76M |
| Accounts Payable | 516K | 1.98M | 12.95M | 7.34M | 6.36M | 4.74M | 5.95M | 5.63M | 5.53M | 6.46M | 5.9M | 6.5M |
| Days Payables Outstanding | - | - | 45.88 | - | - | 46.06 | - | - | - | 93.05 | - | - |
| Short-Term Debt | 38K | 38K | 55K | 0 | 0 | 0 | 0 | 54K | 50K | 0 | 369K | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.97M | 2.07M | 200K | 3.54M | 0 | 0 | 0 | 1.9M | 6.97M | 2.78M | 2.33M | 0 |
| Current Ratio | 27.28x | 35.56x | 8.66x | 1.34x | 2.41x | 3.41x | 3.97x | 27.73x | 12.98x | 5.64x | 7.41x | 7.98x |
| Quick Ratio | 27.28x | 35.56x | 8.66x | 1.34x | 2.41x | 3.41x | 3.97x | 27.73x | 12.98x | 5.64x | 7.41x | 7.98x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 5.12M | 31.99M | 0 | 0 | 0 | 0 | 34.31M | 33.89M | 0 | 0 | 38K |
| Long-Term Debt | 0 | 0 | 1.58M | 0 | 0 | 0 | 0 | 1.65M | 1.66M | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 971K | 0 | 0 | 0 | 0 | 1.45M | 1.04M | 0 | 0 | 38K |
| Deferred Tax Liabilities | 0 | 5.12M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 29.44M | 0 | 0 | 0 | 0 | 31.21M | 31.19M | 0 | 0 | 0 |
| Total Liabilities | 3M | 9.68M | 52.61M | 14.32M | 14.04M | 14.08M | 16.09M | 44.92M | 48.4M | 12.68M | 11.04M | 11.8M |
| Total Debt | 38K | 38K | 3.31M | 39K | 154K | 266K | 376K | 3.88M | 2.88M | 262K | 369K | 474K |
| Net Debt | -6.65M | -14M | -23.45M | -18.09M | -32.56M | -46.98M | -62.45M | -248.13M | -139.24M | -70.38M | -80.37M | -90.94M |
| Debt / Equity | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -688.14x | -5103.00x | -316.60x | -2376.57x | -2571.50x | - | - | - | - | - | - | - |
| Total Equity | 84.38M | 153.51M | 242.22M | 5.72M | 20.84M | 35.05M | 48.95M | 341M | 229.89M | 60.14M | 72.01M | 84.06M |
| Equity Growth % | 304.87% | 337.99% | 394.78% | -98.32% | -90.93% | -41.72% | -32.02% | 305.67% | 711.5% | 10.06% | 13.93% | 30.54% |
| Book Value per Share | 0.50 | 2.17 | 5.84 | 0.14 | 0.50 | 0.85 | 1.19 | 8.72 | 8.51 | 2.23 | 2.67 | 5.71 |
| Total Shareholders' Equity | 84.38M | 153.51M | 242.22M | 5.72M | 20.84M | 35.05M | 48.95M | 341M | 229.89M | 60.14M | 72.01M | 84.06M |
| Common Stock | 94K | 84K | 74K | 41K | 41K | 38K | 38K | 67K | 587K | 26K | 26K | 26K |
| Retained Earnings | -539.72M | -462.55M | -297.35M | -499.45M | -482.81M | -467.37M | -451.94M | -176.43M | -164.72M | -399.58M | -387.12M | -373.42M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -86K | -95K | 114K | -82K | -113K | -120K | 6K | 0 | 0 | 106K | 760K | 414K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |